Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Esophageal Squamous Cell Carcinoma × High-Energy Shock Waves × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 1

Interventions

camrelizumab 2 Cisplatin 2 nimotuzumab 1 atropine sulfate-diphenoxylate hydrochloride drug combination 1 Radiotherapy 1 Paclitaxel 1 Omeprazole 1 Loperamide 1 High-Energy Shock Waves 1 Gastroscopy 1 Drug Therapy 1 Dexamethasone 1 Chemoradiotherapy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07016737 2025-06-12

ESO-Nanjing12

Jiangsu Cancer Institute & Hospital

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡